Truist Financial’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,270
Closed -$269K 2680
2024
Q4
$269K Sell
5,270
-338
-6% -$16.6K ﹤0.01% 2209
2024
Q3
$231K Buy
+5,608
New +$269K ﹤0.01% 2278
2022
Q4
Sell
-3,219
Closed -$234K 2705
2022
Q3
$234K Buy
3,219
+30
+0.9% +$2.23K ﹤0.01% 2217
2022
Q2
$217K Buy
3,189
+342
+12% +$24.6K ﹤0.01% 2415
2022
Q1
$258K Buy
+2,847
New +$233K ﹤0.01% 2400

Other funds holding NARI

Truist Financial's NARI Position: Q1 2025 in Review

Truist Financial sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 5,270 shares — an estimated $269K sold.

Truist Financial first reported a position in NARI in Q1 2022 and held it in 5 quarters. The position peaked at $269K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Truist Financial reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Truist Financial sold 5,270 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $269K.
  • Truist Financial first reported a position in Inari Medical, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Truist Financial's Inari Medical, Inc. Common Stock position peaked at $269K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Truist Financial's 13F filing for Q1 2025, filed 29 Apr 2025.